Emyria Ltd: Letter to Shareholders - Notice of Annual General Meeting
Emyria Ltd: Notice of Annual General Meeting/Proxy Form
Emyria Ltd: Appendix 4G and Corporate Governance Statement
Emyria Ltd: Annual Report
Emyria Ltd: Change of Director's Interest Notice x 2
Emyria Ltd: Section 708A(5)(e) Notice
Emyria Ltd: Notification regarding unquoted securities - EMD
Emyria Ltd: Application for quotation of securities - EMD
Emyria Ltd: 2024 Annual General Meeting - Key Dates
Emyria Ltd: Hidden Gems Webinar Presentation
Emyria Ltd: Emyria Shares Interim Success in PTSD Treatment Program
Emyria Ltd: Appendix 4E & Annual Report for the Year Ended 30 June 2024
Emyria Ltd: Results of Meeting
Emyria Ltd: June 2024 Quarterly Activities Report and Appendix 4C
Emyria Ltd: Letter to Shareholders - Notice of General Meeting
Emyria Ltd: Notice of General Meeting/Proxy Form
Emyria Ltd: Becoming a substantial holder
Emyria Ltd: Ceasing to be a substantial holder
Emyria Ltd: Emyria, UWA Secure $499K Grant for MDMA Analogue Program
Emyria Ltd: Empax Centre Selected As Key Site In Global PTSD Study
No Data
No Data